Hong-Wei Yang

Title: Innovations in Magnetic Nanomedicine by Hong-Wei Yang

Introduction

Hong-Wei Yang is a prominent inventor based in Tao-Yuan, Taiwan. He has made significant contributions to the field of nanomedicine, particularly in the area of tumor suppression and therapy. His innovative approach combines magnetic nanoparticles with therapeutic agents to enhance treatment efficacy.

Latest Patents

Hong-Wei Yang holds a patent for a groundbreaking invention titled "Magnetic nanomedicine for tumor suppression and therapy." This patent describes a magnetic nanomedicine that consists of a core made of magnetic nanoparticles, encapsulated by a shell made of carboxylated polyaniline (SPAnH). The nanomedicine is designed to include a tumor suppression medicine, either Epirubicin (EPI) or Doxorubicin (DOX), which is covalently bonded to the shell. This innovative formulation improves thermal stability and allows for uniform dissolution in water. Its superparamagnetic properties enable it to be guided by an external magnetic field, concentrating the medicine at tumor sites to enhance therapeutic effects.

Career Highlights

Hong-Wei Yang is affiliated with Chang Gung University, where he continues to advance research in nanomedicine. His work has garnered attention for its potential to revolutionize cancer treatment through targeted therapy.

Collaborations

He collaborates with notable colleagues, including Mu-Yi Hua and Cheng-Keng Chuang, who contribute to his research endeavors.

Conclusion

Hong-Wei Yang's innovative work in magnetic nanomedicine represents a significant advancement in cancer therapy. His patented technology has the potential to improve treatment outcomes for patients suffering from tumors.